» Download Public Reports
66 reports
- Company report
- March 2013
- 10 pages
- by Corporation
March 2011
... Investigational car therapy, currently being studied by the university in a pilot clinical trial. -Cart-19 targets a protein called cd19 that is associated with a number of b-cell malignancies such as chronic ...
November 2012
... Represented by its new brand boehringer ingelheim bioxcellence . As a leading biopharmaceutical contract manufactu with more than 35 years of experience The company has brought 19 biopharmaceutical ...
May 2011
... Endpoint value a food-feed context, compositional field trials b environmental context, nto field trials gmo n-i c commercial varieties difference test: gmo versus comparator equivalence test: gmo ...
June 2011
... Ingelheim has brought 17 molecules to market and has many years of experience in multiple molecule classes such as monoclonal antibodies, recombinant proteins, interferons, enzymes, fusion molecules ...
October 2011
... European mab biosimilar guideline overcome the unique manufacturing challenges facing the development of novel therapies such as bi-specifics, antibody fragments, combination antibodies and adcs find novel ...
March 2012
... Ask-force.Org/web/fundamentalists/merritt-moral-self-licensing-2010.Pdf professional framing (herring, 2008): social framing of transgenic crops as Unnatural And Anti-developmental Has obscured variations that matter biologically. Regardless of trait ...
August 2011
... May be marketed in switzerland using the indication Ohne gentechnik hergestellt ( Produced without genetic engineering ) As they are the only products which meet the stringent requirements of food ...
August 2011
... Diagnostics: biomarkers to develop and choose the best therapy industry Aim to provide best care for patient Want higher treatment success and safe drugs physicians patients Want more efficacious ...